Clinical Experience with Preoperative Chemotherapy for Osteosarcoma

  • H. P. Honegger
  • M. Cserhati
  • A. R. von Hochstetter
  • V. Hofmann
  • P. Groscurth
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 98)

Abstract

Since 1978, patients with osteosarcomas have been treated with preoperative chemotherapy (Cserhati et al. 1981). As an additional and important part of our bone sarcoma studies in Zurich, we transplant specimens obtained at the initial biopsy and at the resection after chemotherapy into nude mice for additional evaluation (Groscurth et al. 1982). Several experimental essays for chemosensitivity testing are then performed, as has been outlined elsewhere (Hofmann et al. 1983). An essential and important part is the evaluation by conventional histological analysis and the measurement of necrotic changes in the resected tumors. Our technique for assessment of necrosis has been described elsewhere (Von Hochstetter et al. 1981).

Keywords

Hydration Sarcoma Methotrexate Cyclophosphamide Osteosarcoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cserhati M, Honegger HP, von Hochstetter A, Groscurth P, Hofmann V (1983) Zurich bone sarcome study I. Concepts of the clinical, morphological and functional study. In: Verhandlungen der deutschen Krebsgesellschaft, Vol 4, Fischer, Stuttgart, p 782Google Scholar
  2. Groscurth P, Hofmann V, Cserhati M, von Hochstetter A, Honegger HP (1982) Xenogeneic transplantation and in vitro cultivation of human osteosarcomas after preoperative chemotherapy. Proceedings of the 13th international cancer congress, Sept 13. Abstract 2159, p 379Google Scholar
  3. Honegger HP, von Hochstetter A, Groscurth P, Hofmann V, Cserhati M (1984) The effect of chemotherapy on human bone sarcomas: a clinical and experimental study. In: Hofmann V, Berens ME, Martz G (eds) Predictive drug testing on human tumor cells. Springer, Berlin Heidelberg New York Tokyo, p 65. In: Recent results in cancer research, Vol 94CrossRefGoogle Scholar
  4. Huvos AG, Rosen G, Marcove RL (1977) Primary osteogenic sarcoma. Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection and prosthetic bone replacement. Arch Pathol Lab Med 101:14PubMedGoogle Scholar
  5. Kaplan EZ, Meier P (1958) Non parametric estimation für incomplete observations. J Am Statist Assoc 53:457CrossRefGoogle Scholar
  6. Lange B, Levine AS (1982) Is it ethical not to conduct a prospectively controlled trial of adjuvant chemotherapy in osteosarcoma? Cancer Treat Rep 66:1699PubMedGoogle Scholar
  7. Peto R, Pike M, Armitage P (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1PubMedCrossRefGoogle Scholar
  8. Rosen G, Marcove R, Caparros B, Nirenberg A, Kosloff C, Huvos A (1979) Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163PubMedCrossRefGoogle Scholar
  9. Rosen G, Caparros B, Huvos A, Kosloff C, Nirenberg A, Cacavio A, Marcove R, Lane J, Mehta B, Urban Ch (1982) Preoperative chemotherapy for osteogenic sarcoma. Cancer 19:1221CrossRefGoogle Scholar
  10. Rosen G, Caparros B, Nirenberg A. Cisplatinum-adriamycin combination chemotherapy in evaluable osteogenic sarcoma. Proc Am Soc Clin Oncol 1:173 (abstract C-672)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • H. P. Honegger
    • 1
  • M. Cserhati
    • 1
  • A. R. von Hochstetter
    • 1
  • V. Hofmann
    • 1
  • P. Groscurth
    • 1
  1. 1.FMH Innere Medizin (speziell Hämatologie)Stadtspital TriemliZürichSwitzerland

Personalised recommendations